Sandbox fungal meningitis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 129: | Line 129: | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluconazole]] 400 mg/day'''''<BR>''OR''<BR>▸ '''''[[Itraconazole]] 400 mg/day''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluconazole]] 400 mg/day'''''<BR>''OR''<BR>▸ '''''[[Itraconazole]] 400 mg/day''''' | ||
|-! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Maintenance phase'' | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Maintenance phase'' | |||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluconazole]] 200 mg/day OR''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluconazole]] 200 mg/day OR''''' |
Revision as of 00:47, 19 January 2014
Meningitis Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Sheng Shi, M.D. [2]
fungal meningitis
Blastomyces
|
Candidiasis
|
Histoplasma
|
Coccidioides
|
Cryptococcus, HIV/AIDS
|